NCT06514521View on ClinicalTrials.gov

Post Marketing Study on Pluvicto in Korea

RecruitingOBSERVATIONAL
Enrollment

278

Participants

Timeline

Start Date

April 18, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Metastatic Castration-resistant Prostate Cancer
Interventions
OTHER

Lutetium vipivotide tetraxetan

This is an observational study. There is no treatment allocation. The decision to initiate Lutetium vipivotide tetraxetan will be based solely on clinical judgement.

Trial Locations (1)

Unknown

RECRUITING

Novartis Investigative Site, Seoul

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY